SAMD9L and Ataxia: Here we report two families with SAMD9L variants clinically classified as pathogenic or as a mosaic variant of uncertain significance (VUS) that demonstrate a range of neurologic and hematologic manifestations, and present data on monitoring of ataxia progression using validated methods in two members of family 1.